The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction

[1]  M. Maze,et al.  Role of interleukin‐1β in postoperative cognitive dysfunction , 2010, Annals of neurology.

[2]  R. Gibson,et al.  Transport of interleukin‐1 across cerebromicrovascular endothelial cells , 2009, British journal of pharmacology.

[3]  S. Akira,et al.  ROLE OF TOLL-LIKE RECEPTORS 2 AND 4, AND THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS IN HIGH-MOBILITY GROUP BOX 1-INDUCED INFLAMMATION IN VIVO , 2009, Shock.

[4]  M. Swain,et al.  Cerebral Microglia Recruit Monocytes into the Brain in Response to Tumor Necrosis Factorα Signaling during Peripheral Organ Inflammation , 2009, The Journal of Neuroscience.

[5]  Hippocampus: a future target for sepsis treatment! , 2009, Intensive Care Medicine.

[6]  G. Biondi-Zoccai,et al.  Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction , 2008, Circulation.

[7]  J. Chen,et al.  Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system , 2008, Brain, Behavior, and Immunity.

[8]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[9]  Matthew C. Fister,et al.  Improvement of memory for context by inhibition of caspase‐1 in aged rats , 2005, The European journal of neuroscience.

[10]  N. Rothwell,et al.  Interleukin-1 and neuronal injury , 2005, Nature Reviews Immunology.

[11]  C. Dinarello.  Blocking IL-1 in systemic inflammation , 2005, The Journal of experimental medicine.

[12]  R. Hopkins,et al.  Clinical identification of cognitive impairment in ICU survivors: insights for intensivists , 2004, Intensive Care Medicine.

[13]  Robert Dantzer,et al.  Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. , 2004, European journal of pharmacology.

[14]  M. Feldmann,et al.  Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. , 2004, Blood.

[15]  Hiroki Toda,et al.  Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.

[16]  Peter A. Ward,et al.  Novel strategies for the treatment of sepsis , 2003, Nature Medicine.

[17]  John C. Marshall,et al.  Such stuff as dreams are made on: mediator-directed therapy in sepsis , 2003, Nature Reviews Drug Discovery.

[18]  Jerry W Rudy,et al.  Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus , 2002, Behavioural Brain Research.

[19]  F. Aloisi.  Immune function of microglia , 2001, Glia.

[20]  J. W. Rudy,et al.  The immune system and memory consolidation: a role for the cytokine IL-1β , 2001, Neuroscience & Biobehavioral Reviews.

[21]  J. W. Rudy,et al.  The immune system and memory consolidation: a role for the cytokine IL-1beta. , 2001, Neuroscience and biobehavioral reviews.

[22]  M. Lynch,et al.  Lipopolysaccharide Inhibits Long Term Potentiation in the Rat Dentate Gyrus by Activating Caspase-1* , 2000, The Journal of Biological Chemistry.

[23]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[24]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[25]  J. W. Rudy,et al.  Selective Effects of Peripheral Lipopolysaccharide Administration on Contextual and Auditory-Cue Fear Conditioning , 1998, Brain, Behavior, and Immunity.

[26]  M. Lynch,et al.  Evidence That Increased Hippocampal Expression of the Cytokine Interleukin-1β Is a Common Trigger for Age- and Stress-Induced Impairments in Long-Term Potentiation , 1998, The Journal of Neuroscience.

[27]  S. Maier,et al.  Exposure to Acute Stress Induces Brain Interleukin-1β Protein in the Rat , 1998, The Journal of Neuroscience.

[28]  W. Hickey,et al.  Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat , 1997, Journal of Neuroimmunology.

[29]  M. Fanselow,et al.  Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats , 1997, Behavioural Brain Research.

[30]  K. McIntyre,et al.  Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. , 1997, Journal of immunology.

[31]  T. Fleisher,et al.  Immune function. , 1997, Pediatrics in review.

[32]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[33]  R. Dantzer,et al.  Expression of type I and type II interleukin-1 receptors in mouse brain. , 1994, Brain research. Molecular brain research.

[34]  R. Dantzer.  How do cytokines say hello to the brain? Neural versus humoral mediation. , 1994, European cytokine network.

[35]  M. Brouns,et al.  Immunocytochemical detection of prostaglandin E2 in microvasculature and in neurons of rat brain after administration of bacterial endotoxin , 1993, Brain Research.

[36]  W. Arend.  Interleukin-1 receptor antagonist. , 1993, Advances in immunology.

[37]  W. Arend.  Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. , 1991, The Journal of clinical investigation.

[38]  M. Fanselow,et al.  Conditional and unconditional components of post-shock freezing , 1980, The Pavlovian journal of biological science.